Clinical Trial: Use of Recombinant Factor VII as a Prophylactic Therapy for Adolescent Females With Heavy Menstrual Bleeding
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Assessing the Bleeding Profile and the Quality of Life of the Enrolled Patients Before and 1 Year Af
Study Type: OBSERVATIONAL
Official Title: Professor and Consultant of Pediatric Hematology Faculty of Medicine, Minia University, Al Minya, Egypt.
Brief Summary:
the study is conducted on adolescent females proved to be Glanzmanns Thrombaesthenia with heavy menstrual bleeding by the use of 3 doses of recombinant factor VII in the first day of their cycles.bleeding profile and quality of life were assessed before and 1year after this regular recombinant factor VII administration.
Read more